About 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum
9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum (PubChem CID 162704445) has the molecular formula C77H56F2N5Pt-3
and a molecular weight of 1284.40 g/mol. Its IUPAC name is 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum.
Molecular Properties
| Compound Name | 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum |
| PubChem CID | 162704445 |
| Molecular Formula | C77H56F2N5Pt-3 |
| Molecular Weight | 1284.40 g/mol |
| Exact Mass | 1283.42 |
| IUPAC Name | 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum |
| SMILES | FC(F)(c1[c-]c(N2[CH-]N(c3c(-c4ccccc4)cccc3-c3ccccc3)c3ccccc32)ccc1)c1[c-]c2c(cc1)c1ccccc1n2-c1cc(C2(c3ccc(-n4c5ccccc5c5ccccc54)cc3)C3CC4CC(C3)CC2C4)ccn1.[Pt] |
| InChI | InChI=1S/C77H56F2N5.Pt/c78-77(79,56-21-15-22-61(46-56)81-49-82(72-32-14-13-31-71(72)81)75-62(52-17-3-1-4-18-52)26-16-27-63(75)53-19-5-2-6-20-53)57-35-38-67-66-25-9-12-30-70(66)84(73(67)47-57)74-48-55(39-40-80-74)76(58-42-50-41-51(44-58)45-59(76)43-50)54-33-36-60(37-34-54)83-68-28-10-7-23-64(68)65-24-8-11-29-69(65)83;/h1-40,48-51,58-59H,41-45H2;/q-3; |
| InChIKey | ANMILHRMWFKXQY-UHFFFAOYSA-N |
| XLogP | 19.50 |
| TPSA | 29.23 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 85 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 1284.40 |
| LogP ≤ 5 | 19.50 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Analyze 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum?
The IUPAC name of 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum (CID 162704445) is 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum.
What is the SMILES notation for 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum?
The canonical SMILES for 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum is FC(F)(c1[c-]c(N2[CH-]N(c3c(-c4ccccc4)cccc3-c3ccccc3)c3ccccc32)ccc1)c1[c-]c2c(cc1)c1ccccc1n2-c1cc(C2(c3ccc(-n4c5ccccc5c5ccccc54)cc3)C3CC4CC(C3)CC2C4)ccn1.[Pt].
What is the InChIKey of 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum?
The InChIKey is ANMILHRMWFKXQY-UHFFFAOYSA-N. The full InChI is InChI=1S/C77H56F2N5.Pt/c78-77(79,56-21-15-22-61(46-56)81-49-82(72-32-14-13-31-71(72)81)75-62(52-17-3-1-4-18-52)26-16-27-63(75)53-19-5-2-6-20-53)57-35-38-67-66-25-9-12-30-70(66)84(73(67)47-57)74-48-55(39-40-80-74)76(58-42-50-41-51(44-58)45-59(76)43-50)54-33-36-60(37-34-54)83-68-28-10-7-23-64(68)65-24-8-11-29-69(65)83;/h1-40,48-51,58-59H,41-45H2;/q-3;.
What are the key properties of 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum?
9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum has a molecular weight of 1284.40 g/mol, XLogP of 19.50, 10 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 9-[4-[2-(4-carbazol-9-ylphenyl)-2-adamantyl]-2-pyridinyl]-2-[[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-difluoromethyl]-1H-carbazol-1-ide;platinum is sourced from PubChem (CID 162704445), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).